http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-030077-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8dba007e655b372ab7b6dc30ceed0b5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
filingDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f00f01baa5cf35795bfea1ae56c59dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38e8a9d179dc31d979e0dfa6269ed1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c6c464d4afdf260adbdc293721b1d1
publicationDate 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-030077-B1
titleOfInvention COMBINATION CONTAINING β-HEEL PEPTIDOMOMETIC AND TIGECYCLINE FOR THE TREATMENT OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA, AND ITS APPLICATION
abstract The present invention relates to a combination, a pharmaceutical composition and a kit for the treatment of infections caused by Pseudomonas aeruginosa, or diseases associated with such infections, in humans or animals, containing a β-hairpin peptidomimetic of the formula (I) or its pharmaceutically acceptable salts, or hydrates, or solvates, as well as tigecycline or its pharmaceutically acceptable salts, or hydrates, or solvates. The invention also relates to the use of the claimed combination, pharmaceutical composition and kit for the treatment of infections caused by Pseudomonas aeruginosa, or diseases associated with such infections, in humans or animals. The invention also relates to a method of treating infections caused by Pseudomonas aeruginosa, or diseases associated with such infections, in a human or animal, comprising administering to the subject a claimed combination and / or pharmaceutical composition and / or kit.
priorityDate 2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007079597-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID287
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416047707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600790
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452800996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11622593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16129721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507594
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426222658
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71312020
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID287

Total number of triples: 59.